Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 55, 2021 - Issue 2
Journal homepage
2,769
Views
8
CrossRef citations to date
0
Altmetric
Articles

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate

Kimia Kohestania Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;b Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0003-0244-5508View further author information
ORCID Icon,
Marianne Månssona Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0002-1460-4062View further author information
ORCID Icon,
Rebecka Arnsrud Godtmana Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;b Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0003-2061-6550View further author information
ORCID Icon,
Johan Strannea Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;b Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0002-4295-6524View further author information
ORCID Icon,
Jonas Wallströmc Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Department of Radiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0002-4453-6718View further author information
ORCID Icon,
Sigrid Carlssona Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;e Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USAORCID Iconhttps://orcid.org/0000-0003-3553-5710View further author information
ORCID Icon,
Mikael Hellströmc Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;d Department of Radiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0003-4031-332XView further author information
ORCID Icon &
Jonas Hugossona Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;b Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenCorrespondence[email protected]
View further author information
 show all
Pages 116-124 | Received 02 Nov 2020, Accepted 21 Jan 2021, Published online: 22 Feb 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Karol Axcrona & Sven Löffeler. (2022) A Norwegian perspective on the Swedish national guidelines on prostate cancer for non-metastatic disease. Scandinavian Journal of Urology 56:4, pages 274-276.
Read now
Ola Bratt & Hans Lilja. (2021) Modern prostate cancer diagnostics reduce overdiagnosis – will they open up for population-based screening?. Scandinavian Journal of Urology 55:6, pages 491-492.
Read now

Articles from other publishers (6)

Rebecka Arnsrud Godtman, Karin Stinesen Kollberg, Carl-Gustaf Pihl, Marianne Månsson & Jonas Hugosson. (2022) The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial. European Urology 82:3, pages 311-317.
Crossref
Stephan E. Maier, Jonas Wallström, Fredrik Langkilde, Jens Johansson, Stefan Kuczera, Jonas Hugosson & Mikael Hellström. (2021) Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging : Does the Choice of Diffusion‐Weighting Level Matter? . Journal of Magnetic Resonance Imaging 55:3, pages 842-853.
Crossref
Christoph Würnschimmel, Thenappan Chandrasekar, Luisa Hahn, Tarik Esen, Shahrokh F. Shariat & Derya Tilki. (2022) MRI as a screening tool for prostate cancer: current evidence and future challenges. World Journal of Urology 41:4, pages 921-928.
Crossref
Jonas Wallström, Kjell Geterud, Kimia Kohestani, Stephan E. Maier, Carl-Gustaf Pihl, Andreas Socratous, Johan Stranne, Rebecka Arnsrud-Godtman, Marianne Månsson, Mikael Hellström & Jonas Hugosson. (2022) Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Göteborg Prostate Cancer Screening 2 Trial. European Urology Oncology 5:1, pages 54-60.
Crossref
Sigrid V. Carlsson, Kazunori Murata, Daniel C. Danila & Hans Lilja. 2022. Cancer Biomarkers. Cancer Biomarkers 131 172 .
David Eldred-Evans & Hashim U. Ahmed. (2021) Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography—The IP1-PROSTAGRAM Study—Reply. JAMA Oncology 7:10, pages 1575.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.